Which statement best contrasts dobutamine and dopamine regarding their hemodynamic effects?

Which statement best contrasts dobutamine and dopamine regarding their hemodynamic effects?

• A. Dobutamine is an inodilator with beta-1 agonism and mild vasodilation; dopamine has dose-dependent receptor activation
• B. Dobutamine is a pure vasopressor
• C. Both only activate alpha-1 receptors
• D. Both provide pure vasodilation without inotropy

Answer: (A)

Understanding how these drugs shape hemodynamics is key. Dobutamine mainly drives beta-1 receptors to boost heart muscle contractility, which increases stroke volume and cardiac output. It has little alpha-1 activity, and its beta-2 effects give a bit of vasodilation, so systemic vascular resistance can drop slightly. That combination is why it’s described as an inodilator: it improves pump function with only mild changes in afterload. Dopamine, on the other hand, doesn’t have a single fixed effect. Its impact depends on the dose because it activates different receptors at different levels. At low doses, it mostly acts on D1 receptors, causing vasodilation in renal and mesenteric beds. At moderate doses, it stimulates beta-1 receptors, increasing heart rate and contractility. At high doses, it activates alpha-1 receptors, leading to vasoconstriction and higher systemic vascular resistance. So its hemodynamic effect can range from vasodilation to increased contractility to vasoconstriction, based on how much is given. That contrast—dobutamine’s beta-1–driven inotropy with mild vasodilation versus dopamine’s dose-dependent, receptor-guided spectrum—best captures their differing hemodynamic profiles.

Understanding how these drugs shape hemodynamics is key. Dobutamine mainly drives beta-1 receptors to boost heart muscle contractility, which increases stroke volume and cardiac output. It has little alpha-1 activity, and its beta-2 effects give a bit of vasodilation, so systemic vascular resistance can drop slightly. That combination is why it’s described as an inodilator: it improves pump function with only mild changes in afterload.

Dopamine, on the other hand, doesn’t have a single fixed effect. Its impact depends on the dose because it activates different receptors at different levels. At low doses, it mostly acts on D1 receptors, causing vasodilation in renal and mesenteric beds. At moderate doses, it stimulates beta-1 receptors, increasing heart rate and contractility. At high doses, it activates alpha-1 receptors, leading to vasoconstriction and higher systemic vascular resistance. So its hemodynamic effect can range from vasodilation to increased contractility to vasoconstriction, based on how much is given.

That contrast—dobutamine’s beta-1–driven inotropy with mild vasodilation versus dopamine’s dose-dependent, receptor-guided spectrum—best captures their differing hemodynamic profiles.